ERIN BRIMHALL: Open Payments
NPI 1457349029 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,238 in 111 payments from 24 companies in 2025. Trend: 2023 $1,658 · 2024 $1,925 · 2025 $2,238
Food & beverage: $2,238
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $319 |
| Janssen Biotech, Inc. | 20 | $270 |
| PFIZER INC. | 9 | $236 |
| Regeneron Healthcare Solutions, Inc. | 9 | $188 |
| Galderma Laboratories, L.P. | 9 | $153 |
| Incyte Corporation | 9 | $141 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Amgen Inc. | 5 | $106 |
| UCB, Inc. | 4 | $102 |
| GENZYME CORPORATION | 3 | $99 |
Products named: TREMFYA, DUPIXENT, CIBINQO, SKYRIZI, OPZELURA, RINVOQ, Otezla, COSENTYX.
Industry payments across MD — which companies pay providers there.
